Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 88
1980 126
1981 188
1982 191
1983 263
1984 219
1985 203
1986 201
1987 272
1988 280
1989 247
1990 258
1991 379
1992 312
1993 260
1994 354
1995 411
1996 384
1997 457
1998 390
1999 470
2000 417
2001 500
2002 375
2003 452
2004 457
2005 510
2006 499
2007 519
2008 563
2009 510
2010 496
2011 455
2012 542
2013 572
2014 543
2015 458
2016 457
2017 411
2018 389
2019 481
2020 479
Text availability
Article attribute
Article type
Publication date

Search Results

14,965 results
Results by year
Filters applied: . Clear all
Page 1
2020 International Society of Hypertension Global Hypertension Practice Guidelines.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. Unger T, et al. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6. Hypertension. 2020. PMID: 32370572 No abstract available.
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension.
Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Zhao YC, et al. Hypertension. 2020 Feb;75(2):275-284. doi: 10.1161/HYPERTENSIONAHA.119.13419. Epub 2019 Dec 23. Hypertension. 2020. PMID: 31865799 Review.
Hypertension, a multifactorial disorder resulting from the interplay between genetic predisposition and environmental risk factors, affects 30% of adults. ...Herein, we highlight the epidemiological evidence and putative mechanisms focusing on the emerging roles of NAFLD i
Hypertension, a multifactorial disorder resulting from the interplay between genetic predisposition and environmental risk factors, a
Increased Vascular Contractility in Hypertension Results From Impaired Endothelial Calcium Signaling.
Wilson C, Zhang X, Buckley C, Heathcote HR, Lee MD, McCarron JG. Wilson C, et al. Hypertension. 2019 Nov;74(5):1200-1214. doi: 10.1161/HYPERTENSIONAHA.119.13791. Epub 2019 Sep 23. Hypertension. 2019. PMID: 31542964 Free PMC article.
Basal endothelial Ca(2+) activity limits vascular contraction, but that Ca(2+)-dependent control is impaired in hypertension. When changes in endothelial Ca(2+) levels are buffered, vascular contraction to phenylephrine increased, resulting in similar responses in normoten …
Basal endothelial Ca(2+) activity limits vascular contraction, but that Ca(2+)-dependent control is impaired in hypertension. When ch …
Rediscovering Renovascular Hypertension.
Textor SC, Taler SJ. Textor SC, et al. Hypertension. 2019 Dec;74(6):1297-1299. doi: 10.1161/HYPERTENSIONAHA.119.13515. Epub 2019 Oct 28. Hypertension. 2019. PMID: 31656097 No abstract available.
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study).
Ito S, Itoh H, Rakugi H, Okuda Y, Yoshimura M, Yamakawa S. Ito S, et al. Hypertension. 2020 Jan;75(1):51-58. doi: 10.1161/HYPERTENSIONAHA.119.13569. Epub 2019 Dec 2. Hypertension. 2020. PMID: 31786983 Clinical Trial.
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR blockers are recommended for the treatment of salt-sensitive or resistant hypertension. ...This phase 3 multicenter, randomized, double-blind study compared the efficacy and safety …
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR blockers are recommended for the treatment of s …
Effects of Interleukin-1beta Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS.
Rothman AM, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, Libby P, Glynn RJ, Ridker PM. Rothman AM, et al. Hypertension. 2020 Feb;75(2):477-482. doi: 10.1161/HYPERTENSIONAHA.119.13642. Epub 2019 Dec 30. Hypertension. 2020. PMID: 31884854 Free PMC article. Clinical Trial.
The recent CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) afforded the opportunity to test whether IL (interleukin)-1beta inhibition would reduce blood pressure, prevent incident hypertension, and modify relationships between hypertension and cardi …
The recent CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) afforded the opportunity to test whether IL (interleukin)-1beta …
Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study.
Bigazzi R, Zagato L, Lanzani C, Fontana S, Messaggio E, Delli Carpini S, Citterio L, Simonini M, Brioni E, Magnaghi C, Colombo GI, Santini G, Nistri F, Cellai F, Lenti S, Bianchi S, Pertosa GB, Rocchetti MT, Papale M, Mezzolla V, Gesualdo L, Pina Concas M, Campese V, Manunta P. Bigazzi R, et al. Hypertension. 2020 Jan;75(1):71-78. doi: 10.1161/HYPERTENSIONAHA.119.13818. Epub 2019 Nov 25. Hypertension. 2020. PMID: 31760884
Hypertension and obesity in the young population are major risk factors for renal and cardiovascular events, which could arise in adulthood. ...We tested whether candidate genes previously implicated in salt-sensitive hypertension in adults impact BP also among adol
Hypertension and obesity in the young population are major risk factors for renal and cardiovascular events, which could arise in adu
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, Cai J, Yang R, Han J, Huang Y, He S. Yang G, et al. Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29. Hypertension. 2020. PMID: 32348166
The frequency of ARBs/ACE inhibitors usage in patients with hypertension with or without COVID-19 were comparable. Among patients with COVID-19 and hypertension, those received either ARBs/ACE inhibitors or non-ARBs/ACE inhibitors had comparable blood pressure. ...O …
The frequency of ARBs/ACE inhibitors usage in patients with hypertension with or without COVID-19 were comparable. Among patients wit …
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M; SARS-RAS Investigators. Iaccarino G, et al. Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22. Hypertension. 2020. PMID: 32564693
Several factors have been proposed to explain the high death rate of the coronavirus disease 2019 (COVID-19) outbreak, including hypertension and hypertension-related treatment with Renin Angiotensin System inhibitors. ...At least 1 preexisting condition was observe …
Several factors have been proposed to explain the high death rate of the coronavirus disease 2019 (COVID-19) outbreak, including hyperten
Hypertension: Update 2020.
Dominiczak AF, Meyer TJ. Dominiczak AF, et al. Hypertension. 2020 Jan;75(1):3-4. doi: 10.1161/HYPERTENSIONAHA.119.14352. Epub 2019 Dec 2. Hypertension. 2020. PMID: 31786975 No abstract available.
14,965 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback